Skip to main content
. 2002 Feb;53(2):133–139. doi: 10.1046/j.0306-5251.2001.01182.x

Figure 1.

Figure 1

MEGX (solid symbols) and lignocaine (open symbols) plasma concentration vs time profiles on study day 5 (lignocaine and midazolam, solid line) and study day 10 (lignocaine and midazolam co-administered with erythromycin, dotted line) (mean value and 95% CI).